✦ LIBER ✦

Highly efficient production of anti-HER2 scFv antibody variant for targeting breast cancer cells

✍ Scribed by Silvia Sommaruga; Alessio Lombardi; Agnese Salvadè; Serena Mazzucchelli; Fabio Corsi; Patrizia Galeffi; Paolo Tortora; Davide Prosperi

Book ID: 105953327
Publisher: Springer
Year: 2011
Tongue: English
Weight: 435 KB
Volume: 91
Category: Article
ISSN: 1432-0614
DOI: 10.1007/s00253-011-3306-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Targeting endothelin A receptor enhances

Targeting endothelin A receptor enhances anti-proliferative and anti-invasive effects of the HER2 antibody trastuzumab in HER2-overexpressing breast cancer cells

✍ Jeanett Fischgräbe; Martin Götte; Katharina Michels; Ludwig Kiesel; Pia Wülfing 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 600 KB

Human epidermal growth factor receptor 2 (HER2) is frequently overexpressed in human breast cancers. It is known to drive tumor growth and progression and represents a prominent target in breast cancer therapy. The endothelin (ET) system, in particular ET-1 and its receptor ET A R, is of major relev

Multiple Presentation of Scfv800E6 on Si

Multiple Presentation of Scfv800E6 on Silica Nanospheres Enhances Targeting Efficiency Toward HER-2 Receptor in Breast Cancer Cells

✍ Mazzucchelli, Serena; Verderio, Paolo; Sommaruga, Silvia; Colombo, Miriam; Salva 📂 Article 📅 2011 🏛 American Chemical Society 🌐 English ⚖ 360 KB

Decreased Survival of Human Breast Cance

Decreased Survival of Human Breast Cancer Cells Expressing HER2/neu on In vitro Incubation with an Anti-HER2/neu Antibody Fused to C5a or C5adesArg

✍ Fuenmayor, J.; Perez-Vazquez, K.; Perez-Witzke, D.; Penichet, M. L.; Montano, R. 📂 Article 📅 2010 🏛 American Association for Cancer Research 🌐 English ⚖ 367 KB